A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes
Status:
NOT_YET_RECRUITING
Trial end date:
2027-10-13
Target enrollment:
Participant gender:
Summary
This study is being done to look at how well a study medicine called CagriSema helps people with diabetes lower their blood sugar. In this study the sponsor will compare two version of CagriSema injected by two different types of injection devices. Which treatment participants get is decided by chance. CagriSema is still being tested in studies and is not yet available for doctors to prescribe. The study will last for about 38 weeks.